Press Releases

2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

2014
Dec 2014 | Download as pdf

St. Cloud Surgical Center is First ASC in U.S. to Utilize Xenex Germ-Zapping Robot to Disinfect Operating Rooms & Enhance Patient Safety more

Dec 2014 | Download as pdf

4 cheap small cap stocks Iíve got my eye for Christmas more

Dec 2014 | Download as pdf

Southern Biologics Network Established to Create Biologics Faster and Less Expensively more

Dec 2014 | Download as pdf

Morningside Ministries at the Manor is the First Skilled Nursing Facility in Texas to Protect Residents with Xenex Germ-Zapping Robot more

Dec 2014 | Download as pdf

RBA to cut rates in 2015: Still want to invest in term deposits? more

Nov 2014 | Download as pdf

Can robots help stop the Ebola outbreak? more

Nov 2014 | Download as pdf

Robots Help Fight Ebola more

Nov 2014 | Download as pdf

South Florida Hospital Unveils Ebola-Zapping Robot more

Nov 2014 | Download as pdf

Sonoma Valley Hospital uses robot to kill germs more

Nov 2014 | Download as pdf

Robots go to war against Ebola more

Nov 2014 | Download as pdf

New iTraumaCare CEO to pursue big growth more

Nov 2014 | Download as pdf

UAB and SRI have plans to spinoff more success more

Nov 2014 | Download as pdf

Launch of Galderma's new acne products more

Nov 2014 | Download as pdf

iTraumaCare’s new CEO to help company secure new funding more

Oct 2014 | Download as pdf

U.S. Air Force Hospital Langley Adds Xenex Ebola-Zapping Robot to Inventory more

Oct 2014 | Download as pdf

Forthcoming Acne Treatment Made With Exclusive (And Sustainable) East Indian Sandalwood Oil more

Oct 2014 | Download as pdf

Sonoma Valley Hospital Acquires Xenex Germ-Killing Robot to Enhance Patient Safety more

Oct 2014 | Download as pdf

Robot fights germs at Sharp Chula Vista Medical Center more

Oct 2014 | Download as pdf

Xenex updates protocols for germ-zapping robots in response to Ebola threat more

Oct 2014 | Download as pdf

How do we get rid of the endotoxins? Birmingham's  has the solution more

Oct 2014 | Download as pdf

Medical Device ® Positions New Leader for Next-Level Growth more

Oct 2014 |

The Xenex robot at South Shore Hospital featured on an Xploration Earth more

Oct 2014 | Download as pdf

Germ-zapping robot Gigi sets its sights on Ebola more

Oct 2014 | Download as pdf

Morningside Ventures leads a Series B round for DNAtrix more

Oct 2014 | Download as pdf

StemBioSys secures new research space at BioBridge Global more

Oct 2014 | Download as pdf

Birmingham's Soluble Therapeutics acquires Seattle company Dilyx Biotechnology more

Oct 2014 | Download as pdf

Company invents germ-zapping robot more

Sept 2014 | Download as pdf

Xenex Congratulates Houston Cancer Hospital more

Sept 2014 | Download as pdf

Australian grown Indian Sandalwood timber attracts lucrative Asian markets more

Sept 2014 | Download as pdf

DNATRIX ANNOUNCES TREATMENT OF FIRST PATIENT WITH DNX-2401 more

Sept 2014 | Download as pdf

Targeted Technology raises more than $40 million more

Sept 2014 | Download as pdf

Reducing Healthcare Associated Infections (HAIs): Not All UV Light is the Same more

Sept 2014 | Download as pdf

Bluegrass Vascular Technologies Names Dr. Gabriele Niederauer President And CEO more

Aug 2014 | Download as pdf

Three Birmingham companies recognized in PwC report more

Aug 2014 | Download as pdf

Former Kinetic Concepts Inc. CEO to lead StemBioSys more

Aug 2014 | Download as pdf

International dermatology company Galderma confirmed more

Aug 2014 | Download as pdf

AUSTRALIAN Sandalwood producer TFS Corporation will supply oil more

Aug 2014 | Download as pdf

San Antonio luring biotech firms with venture capital

The process of recruiting health care and bioscience companies to San Antonio has become increasingly competitive as a growing number of cities — including several in Texas — have become far more aggressive in their pursuit of such economic opportunities.

San Antonio bioscience leaders have found a compelling way to attract more of these companies, using venture capital as an appetizing carrot on the proverbial stick.

One of the most recent scores is Bluegrass Vascular Technologies Inc., which has secured $4.5 million in investor funding. San Antonio-based Targeted Technology Fund II, which focuses on early-stage life sciences companies, led the Series A investment. As part of the deal, Bluegrass Vascular, which was launched a few years ago, will relocate its headquarters from Lexington, Ky., to San Antonio.

Bluegrass Vascular plans to use some of the funding on regulatory approval submissions for its Surfacer Inside-Out Access Catheter System. It will also dedicate some of the investor dollars for
manufacturing operations and to obtain a CE Mark for its Surfacer System device. CE Mark approval would give the company the ability to sell its medical devices in the European market.

Approximately 6.5 million patients worldwide require central venous access (CVA) for medical treatment. It is estimated that more than 40 percent of those patients will develop a venous thrombosis, which may compromise their medical care.

After all central veins become compromised, patients must resort to invasive surgical techniques to gain or maintain CVA. The Surfacer System maintains access in an occluded vein, halting the progression to invasive surgery and downstream health risks associated with poor circulation, using a less risky inside-out approach.

Jim Clifton, CEO of Bluegrass Vascular, says the new funding and relocation to San Antonio, where the bioscience industry is critically important, will open more doors for the young company.

“This brings a whole new network of resources we can leverage,” says Clifton about the financial infusion. “We will accelerate some of our plans.”

Equally important is the opportunity Bluegrass Vascular will have to operate in a city that has made it a priority to become a bigger player in the national and international bioscience game.

“We have worked like hell to get this far,” says Clifton about the Bluegrass Vascular team. “Critical mass is meaningful and impactful. This (move) raises our profile.”

Alan Dean, senior managing director of Targeted Technology Fund II and director of Bluegrass Vascular, expects that Bluegrass will see substantial benefits from its new funding, as well as its move to San Antonio.

“The Surfacer System addresses a significant unmet clinical need in the vascular access market by allowing physicians to gain access through a previously occluded vein,” Dean explains. “With a growing market awareness of central venous occlusion and interest in maintaining access, we believe Bluegrass Vascular is well positioned to have a strong presence in the dialysis and chemotherapy markets, and is a valued addition to our investment portfolio.”

W. Scott Bailey covers health care, tourism, sports business, economic development; he also plans and edits some special reports.

 Source: http://www.bizjournals.com/sanantonio/print-edition/2014/08/08/san-antonio-luring-biotech-firms-with-venture.html  back

July 2014 | Download as pdf

Biotech firm secures nearly $5 million in funding, is relocating to San Antonio more

July 2014 | Download as pdf

Birmingham is on the front lines of medical research: take a look at this incredible biotech startup more

July 2014 | Download as pdf

Germ-Zapping Robots Fight C. diff and MRSA at Mercy Health Saint Mary's more

July 2014 | Download as pdf

Milford hospital enlists robots in war against infections more

July 2014 | Download as pdf

Xenex Testifies About UV Room Disinfection Technology Effectiveness to U.S. House of Representatives more

July 2014 | Download as pdf

Western Pa. hospitals test robot using ultraviolet rays to kill bacteria more

July 2014 | Download as pdf

Xenex Demonstrates UV Room Cleaning Systemís Effectiveness in Reducing Hospital Acquired Infections more

July 2014 | Download as pdf

TFS flags record full-year profit more

June 2014 | Download as pdf

Sweet scented sandalwood flavour of month more

June 2014 | Download as pdf

House committee looks for new technology in Veterans Affairs hospitals more

June 2014 | Download as pdf

FDA grants fast track status to drug DNX-2401 for recurrent Glioblastoma more

May 2014 | Download as pdf

CEO shakeup at San Antonio biotech company StemBioSys more

May 2014 | Download as pdf

First harvest to be completed in June more

Mar 2014 | Download as pdf

BiO2 Medical Enrolls Subjects in the New U.S. FDA Early Feasibility Pilot Study for the Angelģ Catheter more

Mar 2014 | Download as pdf

San Antonio biotech firm readies skin treatment for distribution more

Mar 2014 | Download as pdf

ViroXis Gets Approval To Initiate FDA Phase 2 Study For Molluscum Contagiosum more

Mar 2014 | Download as pdf

Medical technologies conference announces speaker lineup more

Mar 2014 | Download as pdf

Australian sandalwood sells for millions more

Mar 2014 | Download as pdf

Sandalwood exports as good as gold more

Feb 2014 | Download as pdf

Santalis Pharmaceuticals Signs Exclusive License Agreement with Global Pharmaceutical Company to Commercialize OTC Dermatology Products more

Feb 2014 | Download as pdf

ViroXis Corporation Signs Exclusive License Agreement with Global Pharmaceutical Company to Commercialize an OTC Dermatology Product more

Feb 2014 | Download as pdf

DNAtrix Awarded $10.8 Million Grant by the Cancer Prevention and Research Institute of Texas more

Feb 2014 | Download as pdf

ViroXis Corporation Achieves Key Clinical Milestones more

Jan 2014 | Download as pdf

There are growing concerns about the threat of an antibiotic crisis caused by the spread of drug-resistant superbugs. Those concerns could result in more